نتایج جستجو برای: ژن brca

تعداد نتایج: 18182  

2016
Rong Bu Abdul K. Siraj Khadija A.S. Al‐Obaisi Shaham Beg Mohsen Al Hazmi Dahish Ajarim Asma Tulbah Fouad Al‐Dayel Khawla S. Al‐Kuraya

Ethnic differences of breast cancer genomics have prompted us to investigate the spectra of BRCA1 and BRCA2 mutations in different populations. The prevalence and effect of BRCA 1 and BRCA 2 mutations in Middle Eastern population is not fully explored. To characterize the prevalence of BRCA mutations in Middle Eastern breast cancer patients, BRCA mutation screening was performed in 818 unselect...

Journal: :Molecular cancer therapeutics 2012
Caroline C Clark Jeffrey N Weitzel Timothy R O'Connor

Individuals with an inherited BRCA1 or BRCA2 mutation have an elevated risk of developing breast cancer. The resulting tumors typically lack homologous recombination repair as do a subset of sporadic tumors with acquired BRCA deficiency. Clinical responses to monotherapy with platinum drugs or poly PARP inhibitors (PARPi) have been shown for BRCA-associated cancers. However, there are limited d...

Journal: :JAMA internal medicine 2013
Victor Grann Maxine Ashby-Thompson

BACKGROUND For women at potentially increased risk for ovarian cancer, data regarding screening and risk reduction are limited. Previous studies have reported on the behaviors of BRCA mutation carriers, but less is known about the behaviors of non- BRCA carriers. We surveyed a large cohort of women after BRCA testing to identify the prevalence and posttest predictors of risk-reducing and screen...

Journal: :Surgery 2011
Cheryl Lin Tina Sasaki Aaron Strumwasser Alden Harken

HYPOTHESIS The DNA base pair sequence in all humans is 99.6% identical and Epigenetic factors influence substantively the RNA processing and translational requisition of the initial DNA message and There are thousands of sequence variants of the BRCA1 and BRCA 2 genes and Family history always trumps BRCA 1 and 2 status so For screening and therapeutic purposes, BRCA 1 and BRCA 2 genetic testin...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013
Hetal S Vig Anne Marie McCarthy Kaijun Liao Mirar Bristol Demeter Tracey Fredericks Katrina Armstrong

BACKGROUND Standard BRCA genetic testing criteria include young age of diagnosis, family history, and Jewish ancestry. The purpose of this study was to assess the effect of these criteria on BRCA test utilization in breast cancer patients. METHODS Breast cancer patients aged 18 to 64 years living in Pennsylvania in 2007 completed a survey on family history of breast and ovarian cancer and BRC...

2017
Daria Fleyshman Laura Prendergast Alfiya Safina Geraldine Paszkiewicz Mairead Commane Kelsey Morgan Kristopher Attwood Katerina Gurova

Although breast cancer (BrCa) may be detected at an early stage, there is a shortage of markers that predict tumor aggressiveness and a lack of targeted therapies. Histone chaperone FACT, expressed in a limited number of normal cells, is overexpressed in different types of cancer, including BrCa. Recently, we found that FACT expression in BrCa correlates with markers of aggressive BrCa, which p...

2012
Ademola Lukman Adelekan Elizabeth Ronami Edoni

Women with Family History (FH) of Breast Cancer (BRCA) in first-degree relative have a relative risk >4 due to inherited genetic mutation genes. This study therefore assessed knowledge and practices of BRCA prevention among women with FH of BRCA in the study area. This is a cross-sectional study. Snowball sampling technique was used to select 189 women with FH of BRCA. A semi-structured questio...

Journal: :Molecular cancer therapeutics 2015
Olga Karginova Marni B Siegel Amanda E D Van Swearingen Allison M Deal Barbara Adamo Maria J Sambade Soha Bazyar Nana Nikolaishvili-Feinberg Ryan Bash Sara O'Neal Katie Sandison Joel S Parker Charlene Santos David Darr William Zamboni Yueh Z Lee C Ryan Miller Carey K Anders

Patients with breast cancer brain metastases have extremely limited survival and no approved systemic therapeutics. Triple-negative breast cancer (TNBC) commonly metastasizes to the brain and predicts poor prognosis. TNBC frequently harbors BRCA mutations translating to platinum sensitivity potentially augmented by additional suppression of DNA repair mechanisms through PARP inhibition. We eval...

2012
Donato F. Romagnolo Ornella Selmin

Epigenetic mechanisms may contribute to reduced expression of the tumor suppressor gene BRCA-1 in sporadic breast cancers. Through environmentalexposure and diet, humans are exposed to xenobiotics and food compounds that bind the aromatic hydrocarbon receptor (AhR). AhR-ligands include the dioxin-like and tumor promoter 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD). The activated AhR r...

Journal: :European urology 2015
Elena Castro Chee Goh Daniel Leongamornlert Ed Saunders Malgorzata Tymrakiewicz Tokhir Dadaev Koveela Govindasami Michelle Guy Steve Ellis Debra Frost Elizabeth Bancroft Trevor Cole Marc Tischkowitz M John Kennedy Jacqueline Eason Carole Brewer D Gareth Evans Rosemarie Davidson Diana Eccles Mary E Porteous Fiona Douglas Julian Adlard Alan Donaldson Antonis C Antoniou Zsofia Kote-Jarai Douglas F Easton David Olmos Rosalind Eeles

BACKGROUND Germline BRCA mutations are associated with worse prostate cancer (PCa) outcomes; however, the most appropriate management for mutation carriers has not yet been investigated. OBJECTIVE To evaluate the response of BRCA carriers to conventional treatments for localised PCa by analysing metastasis-free survival (MFS) and cause-specific survival (CSS) following radical prostatectomy (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید